{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T15:50:18Z","timestamp":1791474618367,"version":"4.3.4"},"reference-count":46,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000923","name":"Silicon Valley Community Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000923","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["biologicalpsychiatryjournal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biological Psychiatry"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1016\/j.biopsych.2012.01.014","type":"journal-article","created":{"date-parts":[[2012,2,18]],"date-time":"2012-02-18T09:46:06Z","timestamp":1329558366000},"page":"956-961","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":264,"title":["A Randomized Controlled Pilot Trial of Oral N-Acetylcysteine in Children with Autism"],"prefix":"10.1016","volume":"71","author":[{"given":"Antonio Y.","family":"Hardan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence K.","family":"Fung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin A.","family":"Libove","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetyana V.","family":"Obukhanych","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surekha","family":"Nair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonore A.","family":"Herzenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas W.","family":"Frazier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rabindra","family":"Tirouvanziam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopsych.2012.01.014_bib1","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/sj.mp.4001499","article-title":"Autism as a disorder of neural information processing: Directions for research and targets for therapy","volume":"9","author":"Belmonte","year":"2004","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.biopsych.2012.01.014_bib2","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1034\/j.1601-183X.2003.00037.x","article-title":"Model of autism: Increased ratio of excitation\/inhibition in key neural systems","volume":"2","author":"Rubenstein","year":"2003","journal-title":"Genes Brain Behav"},{"key":"10.1016\/j.biopsych.2012.01.014_bib3","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1080\/10937400600882079","article-title":"Evidence of toxicity, oxidative stress, and neuronal insult in autism","volume":"9","author":"Kern","year":"2006","journal-title":"J Toxicol Environ Health B Crit Rev"},{"key":"10.1016\/j.biopsych.2012.01.014_bib4","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1212\/WNL.57.9.1618","article-title":"Postmortem brain abnormalities of the glutamate neurotransmitter system in autism","volume":"57","author":"Purcell","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.biopsych.2012.01.014_bib5","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/sj.mp.4000979","article-title":"Linkage and association of the glutamate receptor 6 gene with autism","volume":"7","author":"Jamain","year":"2002","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.biopsych.2012.01.014_bib6","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/ajmg.b.30025","article-title":"Family-based association study between autism and glutamate receptor 6 gene in Chinese Han trios","volume":"131B","author":"Shuang","year":"2004","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"10.1016\/j.biopsych.2012.01.014_bib7","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1007\/s10571-007-9193-6","article-title":"Glutamate receptor 6 gene (GluR6 or GRIK2) polymorphisms in the Indian population: A genetic association study on autism spectrum disorder","volume":"27","author":"Dutta","year":"2007","journal-title":"Cell Mol Neurobiol"},{"key":"10.1016\/j.biopsych.2012.01.014_bib8","doi-asserted-by":"crossref","first-page":"e42","DOI":"10.1136\/jmg.40.4.e42","article-title":"The metabotropic glutamate receptor 8 gene at 7q31: Partial duplication and possible association with autism","volume":"40","author":"Serajee","year":"2003","journal-title":"J Med Genet"},{"key":"10.1016\/j.biopsych.2012.01.014_bib9","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S0006-3223(02)01430-0","article-title":"Glutamic acid decarboxylase 65 and 67 kDa proteins are reduced in autistic parietal and cerebellar cortices","volume":"52","author":"Fatemi","year":"2002","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2012.01.014_bib10","article-title":"Distinct plasma profile of polar neutral amino acids, leucine, and glutamate in children with autism spectrum disorders","author":"Tirouvanziam","year":"2011","journal-title":"J Autism Dev Disord"},{"key":"10.1016\/j.biopsych.2012.01.014_bib11","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1016\/j.pnpbp.2006.06.013","article-title":"Increased serum levels of glutamate in adult patients with autism","volume":"30","author":"Shinohe","year":"2006","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2012.01.014_bib12","first-page":"113","article-title":"Plasma excitatory amino acids in autism","volume":"37","author":"Moreno-Fuenmayor","year":"1996","journal-title":"Invest Clin"},{"key":"10.1016\/j.biopsych.2012.01.014_bib13","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1023\/A:1022238706604","article-title":"Plasma amino acid levels in children with autism and their families","volume":"33","author":"Aldred","year":"2003","journal-title":"J Autism Dev Disord"},{"key":"10.1016\/j.biopsych.2012.01.014_bib14","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1002\/ajmg.b.30366","article-title":"Metabolic endophenotype and related genotypes are associated with oxidative stress in children with autism","volume":"141B","author":"James","year":"2006","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"10.1016\/j.biopsych.2012.01.014_bib15","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1096\/fj.08-128926","article-title":"Cellular and mitochondrial glutathione redox imbalance in lymphoblastoid cells derived from children with autism","volume":"23","author":"James","year":"2009","journal-title":"FASEB J"},{"key":"10.1016\/j.biopsych.2012.01.014_bib16","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1054\/plef.2002.0439","article-title":"Investigation of antioxidant enzymes in children with autistic disorder","volume":"67","author":"Yorbik","year":"2002","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"10.1016\/j.biopsych.2012.01.014_bib17","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.coph.2007.04.005","article-title":"N-Acetylcysteine\u2013a safe antidote for cysteine\/glutathione deficiency","volume":"7","author":"Atkuri","year":"2007","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.biopsych.2012.01.014_bib18","doi-asserted-by":"crossref","first-page":"9134","DOI":"10.1523\/JNEUROSCI.22-20-09134.2002","article-title":"The origin and neuronal function of in vivo nonsynaptic glutamate","volume":"22","author":"Baker","year":"2002","journal-title":"J Neurosci"},{"key":"10.1016\/j.biopsych.2012.01.014_bib19","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.biopsych.2008.03.004","article-title":"N-acetyl cysteine as a glutathione precursor for schizophrenia\u2013a double-blind, randomized, placebo-controlled trial","volume":"64","author":"Berk","year":"2008","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2012.01.014_bib20","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.biopsych.2008.04.022","article-title":"N-acetyl cysteine for depressive symptoms in bipolar disorder\u2013a double-blind randomized placebo-controlled trial","volume":"64","author":"Berk","year":"2008","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2012.01.014_bib21","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1001\/archgenpsychiatry.2009.60","article-title":"N-acetylcysteine, a glutamate modulator, in the treatment of trichotillomania: A double-blind, placebo-controlled study","volume":"66","author":"Grant","year":"2009","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2012.01.014_bib22","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.biopsych.2006.11.021","article-title":"N-acetyl cysteine, a glutamate-modulating agent, in the treatment of pathological gambling: A pilot study","volume":"62","author":"Grant","year":"2007","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2012.01.014_bib23","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1007\/s00213-005-0246-6","article-title":"N-acetylcysteine augmentation in serotonin reuptake inhibitor refractory obsessive-compulsive disorder","volume":"184","author":"Lafleur","year":"2006","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.biopsych.2012.01.014_bib24","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/BF02172145","article-title":"Autism Diagnostic Interview-Revised: A revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders","volume":"24","author":"Lord","year":"1994","journal-title":"J Autism Dev Disord"},{"key":"10.1016\/j.biopsych.2012.01.014_bib25","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1023\/A:1005592401947","article-title":"The Autism Diagnostic Observation Schedule-Generic: A standard measure of social and communication deficits associated with the spectrum of autism","volume":"30","author":"Lord","year":"2000","journal-title":"J Autism Dev Disord"},{"key":"10.1016\/j.biopsych.2012.01.014_bib26","series-title":"ECDEU Assessment Manual for Psychopharmacology","author":"Guy","year":"1976"},{"key":"10.1016\/j.biopsych.2012.01.014_bib27","doi-asserted-by":"crossref","first-page":"4628","DOI":"10.1073\/pnas.0511304103","article-title":"High-dose oral N-acetylcysteine, a glutathione prodrug, modulates inflammation in cystic fibrosis","volume":"103","author":"Tirouvanziam","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biopsych.2012.01.014_bib28","first-page":"492","article-title":"Psychometric characteristics of the aberrant behavior checklist","volume":"89","author":"Aman","year":"1985","journal-title":"Am J Ment Defic"},{"key":"10.1016\/j.biopsych.2012.01.014_bib29","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1097\/00004703-200002000-00002","article-title":"Reciprocal social behavior in children with and without pervasive developmental disorders","volume":"21","author":"Constantino","year":"2000","journal-title":"J Dev Behav Pediatr"},{"key":"10.1016\/j.biopsych.2012.01.014_bib30","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1023\/A:1025014929212","article-title":"Validation of a brief quantitative measure of autistic traits: Comparison of the Social Responsiveness Scale with the Autism Diagnostic Interview-Revised","volume":"33","author":"Constantino","year":"2003","journal-title":"J Autism Dev Disord"},{"key":"10.1016\/j.biopsych.2012.01.014_bib31","series-title":"The Repetitive Behavior Scale: A Test Manual","author":"Bodfish","year":"1998"},{"key":"10.1016\/j.biopsych.2012.01.014_bib32","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1177\/1362361306064434","article-title":"Quantitative assessment of autistic symptomatology in preschoolers","volume":"10","author":"Pine","year":"2006","journal-title":"Autism"},{"key":"10.1016\/j.biopsych.2012.01.014_bib33","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1097\/CHI.0b013e3181b76658","article-title":"A placebo-controlled, fixed-dose study of aripiprazole in children and adolescents with irritability associated with autistic disorder","volume":"48","author":"Marcus","year":"2009","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.biopsych.2012.01.014_bib34","doi-asserted-by":"crossref","first-page":"e634","DOI":"10.1542\/peds.2003-0264-F","article-title":"Risperidone in the treatment of disruptive behavioral symptoms in children with autistic and other pervasive developmental disorders","volume":"114","author":"Shea","year":"2004","journal-title":"Pediatrics"},{"key":"10.1016\/j.biopsych.2012.01.014_bib35","first-page":"91","article-title":"Amantadine and memantine are NMDA receptor antagonists with neuroprotective properties","volume":"43","author":"Kornhuber","year":"1994","journal-title":"J Neural Transm Suppl"},{"key":"10.1016\/j.biopsych.2012.01.014_bib36","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1097\/00004583-200106000-00010","article-title":"Double-blind, placebo-controlled study of amantadine hydrochloride in the treatment of children with autistic disorder","volume":"40","author":"King","year":"2001","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.biopsych.2012.01.014_bib37","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1176\/appi.ajp.161.11.2115","article-title":"A pilot study of D-cycloserine in subjects with autistic disorder","volume":"161","author":"Posey","year":"2004","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2012.01.014_bib38","series-title":"Presented at American Academy of Child and Adolescent Psychiatry Annual Meeting","article-title":"Double-blind placebo-controlled study of D-cycloserine in children with autistic disorder","author":"Posey","year":"2008"},{"key":"10.1016\/j.biopsych.2012.01.014_bib39","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1177\/0883073807302611","article-title":"Memantine as adjunctive therapy in children diagnosed with autistic spectrum disorders: An observation of initial clinical response and maintenance tolerability","volume":"22","author":"Chez","year":"2007","journal-title":"J Child Neurol"},{"key":"10.1016\/j.biopsych.2012.01.014_bib40","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s00213-006-0518-9","article-title":"A retrospective study of memantine in children and adolescents with pervasive developmental disorders","volume":"191","author":"Erickson","year":"2007","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.biopsych.2012.01.014_bib41","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.4088\/JCP.v67n0619h","article-title":"Memantine for disruptive behavior in autistic disorder","volume":"67","author":"Erickson","year":"2006","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.biopsych.2012.01.014_bib42","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1515\/BC.2003.059","article-title":"Glutathione pathways in the brain","volume":"384","author":"Dringen","year":"2003","journal-title":"Biol Chem"},{"key":"10.1016\/j.biopsych.2012.01.014_bib43","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s10803-010-1078-8","article-title":"A pilot randomized controlled trial of omega-3 fatty acids for autism spectrum disorder","volume":"41","author":"Bent","year":"2011","journal-title":"J Autism Dev Disord"},{"key":"10.1016\/j.biopsych.2012.01.014_bib44","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1089\/cap.2008.0123","article-title":"Omega 3 fatty acid treatment in autism","volume":"19","author":"Meiri","year":"2009","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.biopsych.2012.01.014_bib45","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/0278-5846(93)90058-Z","article-title":"A preliminary trial of ascorbic acid as supplemental therapy for autism","volume":"17","author":"Dolske","year":"1993","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2012.01.014_bib46","doi-asserted-by":"crossref","first-page":"123","DOI":"10.2165\/00003088-199120020-00004","article-title":"Clinical pharmacokinetics of N-acetylcysteine","volume":"20","author":"Holdiness","year":"1991","journal-title":"Clin Pharmacokinet"}],"container-title":["Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322312000534?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322312000534?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T15:59:47Z","timestamp":1762099187000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006322312000534"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":46,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["S0006322312000534"],"URL":"https:\/\/doi.org\/10.1016\/j.biopsych.2012.01.014","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718030135.793480154","asserted-by":"object"}]},"ISSN":["0006-3223"],"issn-type":[{"value":"0006-3223","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Randomized Controlled Pilot Trial of Oral N-Acetylcysteine in Children with Autism","name":"articletitle","label":"Article Title"},{"value":"Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopsych.2012.01.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}